A single-center, single-group, observational phase 2 study evaluating HPV-16 Oncoproteins vaccine in women with HPV-16–positive, grade 3 vulvar intraepithelial neoplasia

Trial Profile

A single-center, single-group, observational phase 2 study evaluating HPV-16 Oncoproteins vaccine in women with HPV-16–positive, grade 3 vulvar intraepithelial neoplasia

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Dec 2017

At a glance

  • Drugs ISA 101 (Primary)
  • Indications Vulvar intraepithelial neoplasia
  • Focus Proof of concept; Therapeutic Use
  • Sponsors ISA Pharmaceuticals
  • Most Recent Events

    • 22 Dec 2017 New trial record
    • 05 Nov 2009 Results published in The New England Journal of Medicine.
    • 05 Nov 2009 This study was sponsored by the Dutch Cancer Society, the European Union and Pharmaceuticals, as reported in an article published at The New England Journal of Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top